Traders looked unfavorably on Apellis Pharmaceuticals stock on Monday, after an internal report into the safety of its newly-approved Syfovre (pegcetacoplan) de 1 August 2023
AstraZeneca has reported total revenues of $11.4 billion in the second quarter, a rise of around 6%, beating expectations from most analysts. 28 July 2023
French drugmaker Sanofi has reported net sales for the second quarter of $9.9 billion euros ($10.9 billion), a 1.5% fall, with net income of 1.4 billion euros a 28 July 2023
French drugmaker Ipsen has reported a 7.2% increase in revenues in the first quarter, driven in part by newly-acquired medicines Bylvay (odevixibat) and Tazveri 27 July 2023
Shares in Stoke Therapeutics have fallen by a third after the company announced what it described as “positive new safety and efficacy data” from its early stag 26 July 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.